Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Ramos-Esquivel

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Cureus|December 24, 2025
Efficacy of Pembrolizumab as Conversion Therapy in Deficient Mismatch Repair/Microsatellite Instability-High Metastatic Liver Colorectal Cancer Associated With Lynch Syndrome: A Case-Based AnalysisAndrés de Jesús León-Sandí, Jimena Agüero-Moraga, Allan Ramos-Esquivel
Breast Cancer (Tokyo, Japan)|February 23, 2018
Cyclin-dependent kinase 4/6 inhibitors as first-line treatment for post-menopausal metastatic hormone receptor-positive breast cancer patients: a systematic review and meta-analysis of phase III randomized clinical trialsAllan Ramos-Esquivel, Hellen Hernández-Steller, Marie-France Savard, et al.
Journal of Global Oncology|December 16, 2017
Epidemiology and Outcomes of Bloodstream Infections in Patients With Solid Tumors in a Central American Population at Mexico Hospital, San Jose, Costa RicaJorge Calvo-Lon, Denis U Landaverde, Allan Ramos-Esquivel, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|April 7, 2020
Subcutaneous Tocilizumab in Monotherapy or in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Latin American Patients With Moderate to Severe Active Rheumatoid Arthritis: A Multicenter, Phase IIIb StudyEduardo Mysler, Mario H Cardiel, Ricardo M Xavier, et al.
Journal of Thrombosis and Thrombolysis|July 5, 2023
Comparison among three predictive models for cancer-associated thromboembolism in a hispanic populationAllan Ramos-Esquivel, Ana Marenco-Flores, Gabriel Hernández-Romero, et al.
ESMO Open|November 29, 2017
Anti-PD-1/anti-PD-L1 immunotherapy versus docetaxel for previously treated advanced non-small cell lung cancer: a systematic review and meta-analysis of randomised clinical trialsAllan Ramos-Esquivel, Alicia van der Laat, Raquel Rojas-Vigott, et al.
Journal of Medical Economics|March 28, 2019
Time spent on erythropoietin stimulating agents administration in hemodialysis centers in Panama: a time and motion studyMarianne Chacón-Araya, Diego Rey-Rodríguez, Felipe Rodríguez De León, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 28, 2020
Barriers to lung cancer referral, diagnosis, and treatment in Central America and the Caribbean: the health professionals' perspectivesAziza Maklouf-Quirós, Johayra Simithy, Kavita Ragoobar, et al.
Brain Tumor Research and Treatment|February 9, 2026
The Dual Impact of Glioma Resection on Survival and Health-Related Quality of Life: Resect More, Live BetterMiguel Esquivel-Miranda, Dessiré Gutiérrez-Gutiérrez, Emmanuelle Vargas-Valenciano, et al.
Ecancermedicalscience|February 23, 2023
Using the Khorana risk score to predict venous thromboembolism and overall survival in a cohort of Hispanic patients with solid malignanciesAllan Ramos-Esquivel, Ana Marenco-Flores, Gabriel Hernández-Romero, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Cureus|December 24, 2025
Efficacy of Pembrolizumab as Conversion Therapy in Deficient Mismatch Repair/Microsatellite Instability-High Metastatic Liver Colorectal Cancer Associated With Lynch Syndrome: A Case-Based AnalysisAndrés de Jesús León-Sandí, Jimena Agüero-Moraga, Allan Ramos-Esquivel
Breast Cancer (Tokyo, Japan)|February 23, 2018
Cyclin-dependent kinase 4/6 inhibitors as first-line treatment for post-menopausal metastatic hormone receptor-positive breast cancer patients: a systematic review and meta-analysis of phase III randomized clinical trialsAllan Ramos-Esquivel, Hellen Hernández-Steller, Marie-France Savard, et al.
Journal of Global Oncology|December 16, 2017
Epidemiology and Outcomes of Bloodstream Infections in Patients With Solid Tumors in a Central American Population at Mexico Hospital, San Jose, Costa RicaJorge Calvo-Lon, Denis U Landaverde, Allan Ramos-Esquivel, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|April 7, 2020
Subcutaneous Tocilizumab in Monotherapy or in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Latin American Patients With Moderate to Severe Active Rheumatoid Arthritis: A Multicenter, Phase IIIb StudyEduardo Mysler, Mario H Cardiel, Ricardo M Xavier, et al.
Journal of Thrombosis and Thrombolysis|July 5, 2023
Comparison among three predictive models for cancer-associated thromboembolism in a hispanic populationAllan Ramos-Esquivel, Ana Marenco-Flores, Gabriel Hernández-Romero, et al.
ESMO Open|November 29, 2017
Anti-PD-1/anti-PD-L1 immunotherapy versus docetaxel for previously treated advanced non-small cell lung cancer: a systematic review and meta-analysis of randomised clinical trialsAllan Ramos-Esquivel, Alicia van der Laat, Raquel Rojas-Vigott, et al.
Journal of Medical Economics|March 28, 2019
Time spent on erythropoietin stimulating agents administration in hemodialysis centers in Panama: a time and motion studyMarianne Chacón-Araya, Diego Rey-Rodríguez, Felipe Rodríguez De León, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 28, 2020
Barriers to lung cancer referral, diagnosis, and treatment in Central America and the Caribbean: the health professionals' perspectivesAziza Maklouf-Quirós, Johayra Simithy, Kavita Ragoobar, et al.
Brain Tumor Research and Treatment|February 9, 2026
The Dual Impact of Glioma Resection on Survival and Health-Related Quality of Life: Resect More, Live BetterMiguel Esquivel-Miranda, Dessiré Gutiérrez-Gutiérrez, Emmanuelle Vargas-Valenciano, et al.
Ecancermedicalscience|February 23, 2023
Using the Khorana risk score to predict venous thromboembolism and overall survival in a cohort of Hispanic patients with solid malignanciesAllan Ramos-Esquivel, Ana Marenco-Flores, Gabriel Hernández-Romero, et al.
Pageof 4